Skip to main content
OpenTrials

Clinical trial condition

HR Positive/HER2 Low Expression Metastatic Breast Cancer

Explore clinical trials studying HR Positive/HER2 Low Expression Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

HR Positive/HER2 Low Expression Metastatic Breast Cancer trial results

Recruiting

Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)

NCT05904964

Conditions
Breast Diseases, Breast Neoplasms, HR Positive/HER2 Low Expression Metastatic Breast Cancer, +4 more
Locations
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital， Shantou University Medical College Shantou, Guangdong, China
  • Hainan Qionghai People's Hospital Qionghai, Hainan, China
View Trial Details

Related conditions